🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
The main purpose of this study was to evaluate the rate of deep molecular r...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-02-18
Trial ID
NCT02546674
Treatments Being Tested
This is an institutional cohort study. Patients confirmed with spinocerebel...
Status
Completed
Location
Seoul National University Hospital
Start Date
2018-11-19
Trial ID
NCT03932669
Treatments Being Tested
The extension study followed the core study CAMN107ECN02 (NCT01275196). whi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-07-17
Trial ID
NCT02272777
Chronic Graft versus Host Disease (cGvHD) has been identified as the leadin...
Status
Completed
Location
Chaim Sheba Medical Center
Start Date
2011-11
Trial ID
NCT01810718
Treatments Being Tested
This study will assess the safety and tolerability of daily oral administra...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-10-16
Trial ID
NCT03205488
The purpose of this Australian study was to assess the efficacy and safety ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-07-07
Trial ID
NCT02108951
Treatments Being Tested
This study aimed to assess the optimal duration of nilotinib 300 mg twice d...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-04-15
Trial ID
NCT01743989
Treatments Being Tested
This study is to determine the number of European Leukemia Network (ELN)gui...
Status
Terminated
Location
Comprehensive Cancer Centers of Nevada CCC of Nevada (1)
Start Date
2010-10-21
Trial ID
NCT01131325
Treatments Being Tested
To evaluate efficacy, safety and pharmacokinetic profile of asciminib 40mg+...
Status
Completed
Location
Georgia Regents University
Start Date
2018-11-22
Trial ID
NCT03578367
Treatments Being Tested